Group B Strep Awareness
Prevention Guidelines - Canada
Home
Guidelines - USA
Guidelines - Canada
Guidelines - UK
From the Experts
Mom to Mom
Support
Resources

Clinical Practice Guidelines for Group B Strep Prevention issued by the Society of Obstetricians and Gynecologists September 2004

The Prevention of Early-Onset Neonatal Group BStreptococcal Disease  J Obstet Gynaecol Can 2004;26(9):826–32.

See also the unique guidelines for the United States and the United Kingdom.

Horizontal Divider 25

1. Offer all women screening for group B streptococcal disease at 35 to 37 weeks’ gestation with culture done from one swab first to the vagina then to the rectal area. (II-1)

2. Treat the following women intrapartum at time of labour or rupture of membranes with IV  antibiotics:

• all women positive by GBS culture screening done at 35 to 37 weeks (II-2)
• any women with an infant previously infected with GBS (II-3)
• any women with documented GBS bacteriuria (regardless of level of colony-forming units per mL) in this pregnancy (II-2)

3. Treat women at less than 37 weeks’ gestation with IV antibiotics unless there has been a negative GBS vaginal/rectal swab culture within 5 weeks. (II-3)

4. Treat women with intrapartum fever with IV antibiotics (i.e., chorioamnionitis must be treated, but broader spectrum antibiotics would be advised). (II-2)

5. If a woman is GBS-positive by culture screening or by history of bacteriuria, with prelabour rupture of membranes at term, treat with GBS antibiotic prophylaxis and initiate induction of labour with IV oxytocin (II-1)

6. If GBS culture result is unknown and the woman has ruptured membranes at term for greater than 18 hours, treat with GBS antibiotic prophylaxis. (II-2)

To read more information on Group B Strep in Canada see this list of  Canadian Group B Strep Resources

visits since December 10, 2002